Scotia Capital’s St Jude Medical STJ Stock Holding History

Scotia Capital’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-44,754	Closed	-$3.59M	–	885
2016 Q4	$3.59M	Buy	44,754 +139	+0.3%	+$11K	0.06%	212
2016 Q3	$3.56M	Sell	44,615 -740	-2%	-$59.7K	0.07%	202
2016 Q2	$3.54M	Sell	45,355 -226	-0.5%	-$16.1K	0.07%	183
2016 Q1	$2.51M	Buy	45,581 +42,381	+1,324%	+$2.31M	0.05%	207
2015 Q4	$202K	Hold	3,200	–	–	﹤0.01%	738
2015 Q3	$202K	Buy	+3,200	New	+$228K	﹤0.01%	713

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Scotia Capital's STJ Position: Q1 2017 in Review

Scotia Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 44,754 shares — an estimated $3.59M sold.

Scotia Capital first reported a position in STJ in Q3 2015 and held it in 6 quarters. The position peaked at $3.59M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Scotia Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Scotia Capital sold 44,754 St Jude Medical shares in Q1 2017, an estimated $3.59M.
Scotia Capital first reported a position in St Jude Medical in Q3 2015 and held it in 6 quarters.
Scotia Capital's St Jude Medical position peaked at $3.59M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Scotia Capital's 13F filing for Q1 2017, filed 15 May 2017.